Triple Board-certified Expertise

×

Triple Board-certified Expertise

Lashes and Brows

To schedule an appointment

Call Us

(470) 769-9400
LATISSE®
All images © 2020 Allergan
Closeup on a woman’s eyebrows and eyes. She has very few thin eyelashes. After Latisse treatment she has fuller and thicker lashes.

Indications, Important Safety Information and Prescribing Information

Toggle

LATISSE® (bimatoprost ophthalmic solution) 0.03% Important Information

Indication

LATISSE® (bimatoprost ophthalmic solution) 0.03% is indicated to treat hypotrichosis of the eyelashes by increasing their growth, including length, thickness, and darkness.

Important Safety Information

ContraindicationsLATISSE® is contraindicated in patients with hypersensitivity to bimatoprost or to any of the ingredients.

Warnings and Precautions: In patients using LUMIGAN® (bimatoprost ophthalmic solution) or other prostaglandin analogs for the treatment of elevated intraocular pressure (IOP), the concomitant use of LATISSE® may interfere with the desired reduction in IOP. Patients using prostaglandin analogs including LUMIGAN® for IOP reduction should only use LATISSE® after consulting with their physician and should be monitored for changes to their intraocular pressure.

Increased iris pigmentation has occurred when bimatoprost solution was administered. Patients should be advised about the potential for increased brown iris pigmentation, which is likely to be permanent.

Bimatoprost has been reported to cause pigment changes (darkening) to periorbital pigmented tissues and eyelashes. The pigmentation is expected to increase as long as bimatoprost is administered, but has been

reported to be reversible upon discontinuation of bimatoprost in most patients.

There is the potential for hair growth to occur in areas where LATISSE® solution comes in repeated contact with skin surfaces. Apply LATISSE® only to the skin of the upper eyelid margin at the base of the eyelashes.

LATISSE® solution should be used with caution in patients with active intraocular inflammation (eg, uveitis) because the inflammation may be exacerbated. LATISSE® should be used with caution in aphakic patients, in pseudophakic patients with a torn posterior lens capsule, or in patients with known risk factors for macular edema.

Adverse Reactions: The most frequently reported adverse events were eye pruritus, conjunctival hyperemia, skin hyperpigmentation, ocular irritation, dry eye symptoms, and periorbital erythema. These reactions occurred in less than 4% of patients.

Postmarketing Experience: The following adverse reactions have been identified during postapproval use of LATISSE®: dry skin of the eyelid and/or periocular area, eye swelling, eyelid edema, hypersensitivity (local allergic reactions), lacrimation increased, madarosis and trichorrhexis (temporary loss of a few eyelashes to loss of sections of eyelashes, and temporary eyelash breakage, respectively), periorbital and lid changes associated with a deepening of the eyelid sulcus, rash (including macular and erythematous), skin discoloration (periorbital), and vision blurred.

Please see LATISSE® full Prescribing Information.

Are you camera ready?


Why opt for eyelash extensions, eyebrow extensions, and other needless solutions when you can bring out the natural potential of your own lashes, brows, and hair? Springs Dermatology MD offers safe, effective, and easy options in the heart of Sandy Springs and Metro Atlanta.


We offer many non-surgical treatment options that are prescribed by physicians only, such as Latisse, Neulash, Neubrow, and Neutraceuticals that will enhance your brows and lashes hair growth. In addition, we offer transplant solutions that will help you achieve permanent and natural-looking results. Our expertise, professionalism and personalized care add to the impressive results.


Latisse

Want thick long eyelashes and eyelash growth? Latisse is an FDA approved medical treatment that transforms inadequate eyelashes into thicker and longer lashes in just a few weeks. The Latisse before and after difference is eye-catching! Are you a candidate?


Neulash/ Neubrow
Want thicker, healthier brows or fuller lashes? Neulash and Neubrow are gentle yet professional formulas of botanicals and antioxidants for your eyebrows and eyelashes. The result is a fuller look in a few weeks. Curious yet?


Neutraceuticals

Let your hair shine stronger, thicker and longer than ever! Neutraceuticals are luxury products in the wellness sector, and our dermatologist has hand-picked a special selection from Hush and Hush, Viviscal, and Nutrafol. Which one is best for you?

LATISSE®
All images © 2020 Allergan
Closeup on a woman’s eyebrows and eyes. She has very few thin eyelashes. After Latisse treatment she has fuller and thicker lashes.

Indications, Important Safety Information and Prescribing Information

Toggle

LATISSE® (bimatoprost ophthalmic solution) 0.03% Important Information

Indication

LATISSE® (bimatoprost ophthalmic solution) 0.03% is indicated to treat hypotrichosis of the eyelashes by increasing their growth, including length, thickness, and darkness.

Important Safety Information

ContraindicationsLATISSE® is contraindicated in patients with hypersensitivity to bimatoprost or to any of the ingredients.

Warnings and Precautions: In patients using LUMIGAN® (bimatoprost ophthalmic solution) or other prostaglandin analogs for the treatment of elevated intraocular pressure (IOP), the concomitant use of LATISSE® may interfere with the desired reduction in IOP. Patients using prostaglandin analogs including LUMIGAN® for IOP reduction should only use LATISSE® after consulting with their physician and should be monitored for changes to their intraocular pressure.

Increased iris pigmentation has occurred when bimatoprost solution was administered. Patients should be advised about the potential for increased brown iris pigmentation, which is likely to be permanent.

Bimatoprost has been reported to cause pigment changes (darkening) to periorbital pigmented tissues and eyelashes. The pigmentation is expected to increase as long as bimatoprost is administered, but has been

reported to be reversible upon discontinuation of bimatoprost in most patients.

There is the potential for hair growth to occur in areas where LATISSE® solution comes in repeated contact with skin surfaces. Apply LATISSE® only to the skin of the upper eyelid margin at the base of the eyelashes.

LATISSE® solution should be used with caution in patients with active intraocular inflammation (eg, uveitis) because the inflammation may be exacerbated. LATISSE® should be used with caution in aphakic patients, in pseudophakic patients with a torn posterior lens capsule, or in patients with known risk factors for macular edema.

Adverse Reactions: The most frequently reported adverse events were eye pruritus, conjunctival hyperemia, skin hyperpigmentation, ocular irritation, dry eye symptoms, and periorbital erythema. These reactions occurred in less than 4% of patients.

Postmarketing Experience: The following adverse reactions have been identified during postapproval use of LATISSE®: dry skin of the eyelid and/or periocular area, eye swelling, eyelid edema, hypersensitivity (local allergic reactions), lacrimation increased, madarosis and trichorrhexis (temporary loss of a few eyelashes to loss of sections of eyelashes, and temporary eyelash breakage, respectively), periorbital and lid changes associated with a deepening of the eyelid sulcus, rash (including macular and erythematous), skin discoloration (periorbital), and vision blurred.

Please see LATISSE® full Prescribing Information.

Call us to schedule an appointment
ABD-Certification ABD-Certification ABD-Certification

JOIN OUR MAILING LIST

×

Thank you for signing up.

Send

Call Us Call (470) 769-9400